News & Library

4BIO Capital - Appointment of Professor Akiko Iwasaki to Scientific Advisory Board

Appointment of Professor Akiko Iwasaki to Scientific Advisory Board. Professor of Molecular, Cellular and Developmental Biology and Immunology at Yale University - Principal investigator at the Howard Hughes Medical Institute. Brings extensive experience in Immunology within the field of infectious diseases, most recently in COVID-19.

4BIO Capital - 4BIO invests in Araris Biotech AG’s CHF 15.2 million seed financing round

4BIO Capital announces its investment in Araris Biotech AG, a company pioneering an antibody-drug conjugate (ADC)-linker technology. Araris announced today that it has received an additional CHF 12.7 million in its seed financing round, bringing the total amount raised to CHF 15.2 million. Dmitry Kuzmin, Managing Partner at 4BIO Capital, will join Araris’ Board.